Press Release | NeoGenomics Laboratories

December 10, 2021

NeoGenomics to Leverage Thermo Fisher Scientific’s Ion Torrent Genexus System in Upcoming Phase 1 Study for Myeloid Cancers

November 30, 2021

NeoGenomics To Participate In The Stephens Annual Investment Conference 2021

November 10, 2021

NeoGenomics Appoints Dave Daly to Its Board of Directors

November 4, 2021

NeoGenomics Announces Leadership Team Transition

November 4, 2021

NeoGenomics Reports Revenue of $121 Million in the Third Quarter

October 19, 2021

NeoGenomics' Liquid Biopsy Subsidiary Inivata Announces Clinical Collaboration With Princess Margaret Cancer Center for the Use of Its Liquid Biopsy Assays

September 9, 2021

NeoGenomics' Liquid Biopsy Subsidiary Inivata and Collaborators to Present Data that Further Validate the Application of its RaDaR™ MRD and InVisionFirst®-Lung Assays at the ESMO Congress 2021

September 1, 2021

NeoGenomics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients